NanoString Technologies: Teresa Foy
NanoString Technologies has appointed Teresa Foy to its board of directors. Foy leads the Immuno-Oncology and Cell Therapy Thematic Research Center at Bristol Myers Squibb. Prior to Bristol Myers Squibb, she worked at Celgene for more than five years. Foy holds a PhD in immunology from the University of Iowa and completed her post-doctoral fellowship in immunology and immunotherapy at Dartmouth Medical School. She received an MS in immunology and microbiology from St. Cloud State University and a BS in biology from the University of Minnesota.